首页> 外文OA文献 >Comparison of High-Dose Gemcitabine, Busulfan and Melphalan (GEM/BU/MEL) and BEAM in Concurrent Patient Cohorts with Mature T-CELL NON-Hodgkin's Lymphoma (T-NHL) Receiving an Autologous Stem Cell Transplantation (ASCT)

【2h】

Comparison of High-Dose Gemcitabine, Busulfan and Melphalan (GEM/BU/MEL) and BEAM in Concurrent Patient Cohorts with Mature T-CELL NON-Hodgkin's Lymphoma (T-NHL) Receiving an Autologous Stem Cell Transplantation (ASCT)

机译：高剂量吉西他滨，伯林和梅酚（宝石/梅兰（Gem / Bu / Mel）和梁在同时患者群中的成熟T细胞非霍奇金淋巴瘤（T-NHL）接受自体干细胞移植（ASCT）

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Yago Nieto; Roland Bassett; Chitra Hosing; Roy B. Jones; Ben C. Valdez; Ashley Kingham; Sairah Ahmed; Amin M. Alousi; Paolo Anderlini; Uday R. Popat; Muzaffar H. Qazilbash; Elizabeth J. Shpall; Partow Kebriaei; Jonathan E. Brammer; Yasuhiro Oki; Michelle A. Fanale; Farzaneh Maadani; Gabriela Rondon; Richard E. Champlin; Borje S. Andersson;
展开▼
作者单位

展开▼
年度 2016
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献

1. Comparison of High-Dose Gemcitabine, Busulfan and Melphalan (GEM/BU/MEL) and BEAM in Concurrent Patient Cohorts with Mature T-CELL NON-Hodgkin's Lymphoma (T-NHL) Receiving an Autologous Stem Cell Transplantation (ASCT) [J] . Nieto Yago, Bassett Roland, Hosing Chitra, Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2016 ,第3Suppla1期

机译：高剂量吉西他滨，白消安和美法仑（GEM / BU / MEL）和BEAM在接受自体干细胞移植（ASCT）的成熟T细胞非霍奇金淋巴瘤（T-NHL）并发患者队列中的比较
2. Vorinostat Combined with High-Dose Gemcitabine, Busulfan, and Melphalan with Autologous Stem Cell Transplantation in Patients with Refractory Lymphomas [J] . Nieto Yago, Valdez Benigno C., Thall Peter F., Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2015 ,第11期

机译：伏立诺他联合大剂量吉西他滨，白消安和美法仑联合自体干细胞移植治疗难治性淋巴瘤患者
3. Toxicities and Outcomes for Patients with CNS Lymphoma (CNSL) Consolidated with High-Dose Therapy and Autologous Stem Cell Transplantation (HDT-ASCT) Using Thiotepa, Pharmacokinetically-Targeted (PR) Busulfan (Bu), Cyclophosphamide (TBC) Conditioning [J] . Scordo Michael, Bhatt Valkal, Hsu Meier, Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2016 ,第3Suppla1期

机译：使用Thiotepa，药代动力学靶向（PR）白消安（Bu），环磷酰胺（TBC）调理的高剂量治疗和自体干细胞移植（HDT-ASCT）合并的中枢神经系统淋巴瘤（CNSL）患者的毒性和结果
4. HIGH-DOSE MELPHALAN CHEMOTHERAPY WITH AUTOLOGOUS STEM CELL TRANSPLANTATION IN 65 PATIENTS WITH AL AMYLOIDOSIS: ORGAN PROGRESSION CAN BE DELAYED IN PATIENTS REACHING COMPLETE REMISSION [C] . SO Schonland, J.B Dengler, M Hundemer, International Symposium on Amyloidosis . 2008

机译：在65例Al淀粉样蛋白患者中，具有自体蛋白化疗的高剂量蛋白化疗：器官进展可以延迟达到完全缓解的患者
5. Correlates of fatigue in lymphoma patients undergoing autologous peripheral blood stem cell transplantation. [D] . El-Banna, Majeda Mohammed. 2004

机译：与进行自体外周血干细胞移植的淋巴瘤患者疲劳相关。
6. Vorinostat Combined with High-Dose Gemcitabine Busulfan and Melphalan with Autologous Stem Cell Transplantation in Patients with Refractory Lymphomas [O] . Yago Nieto, Benigno C. Valdez, Peter F. Thall, -1

机译：伏立诺他联合大剂量吉西他滨白消安和美法仑联合自体干细胞移植治疗难治性淋巴瘤患者
7. Comparison of Gemcitabine, Busulfan and Melphalan (Gem/Bu/Mel) with Beam and Busulfan/Melphalan (Bu/Mel) in Concurrent Cohorts of Refractory Hodgkin'S Lymphoma (HL) Patients Receiving an Autologous Stem-Cell Transplant [O] . Nieto Y., Jones R.B., Liu P., 2012

机译：吉西他滨，白消安和美法仑（Gem / Bu / Mel）与束和白消安/美法仑（Bu / Mel）在难治性霍奇金淋巴瘤（HL）并发自体干细胞移植患者中的比较

Comparison of High-Dose Gemcitabine, Busulfan and Melphalan (GEM/BU/MEL) and BEAM in Concurrent Patient Cohorts with Mature T-CELL NON-Hodgkin's Lymphoma (T-NHL) Receiving an Autologous Stem Cell Transplantation (ASCT)

著录项

相似文献

相关主题

期刊订阅